Indeed, Tp53 has been shown to control plasticity in a number of different cellular contexts18 and thus Tp53 mutations may facilitate such transdifferentiation events that are implicated in hepatocyte-derived ICC pathogenesis19. The gene discussed is TP53; the disease is intrahepatic cholangiocarcinoma.